INDICATION: QUZYTTIR is
indicated for the treatment of acute urticaria in adults and
children 6 months of age and older.
Limitations of Use: QUZYTTIR is not recommended in pediatric patients <6 years
of age with impaired renal or hepatic function.
If you click “Continue” below, you will leave the current site.
TerSera is not responsible for the privacy policy of any
third-party websites. We encourage you to read the privacy policy
of every website you visit.
The information contained in this section of the site is intended
for US Healthcare Professionals only. Click Continue if you are a
US Healthcare Professional.